دورية أكاديمية

Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

التفاصيل البيبلوغرافية
العنوان: Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial
المؤلفون: Ascierto, Paolo A.Aff1, IDs41467023444756_cor1, Casula, Milena, Bulgarelli, Jenny, Pisano, Marina, Piccinini, Claudia, Piccin, Luisa, Cossu, Antonio, Mandalà, MarioAff6, Aff7, Ferrucci, Pier Francesco, Guidoboni, Massimo, Rutkowski, Piotr, Ferraresi, Virginia, Arance, Ana, Guida, Michele, Maiello, Evaristo, Gogas, Helen, Richtig, Erika, Fierro, Maria Teresa, Lebbe, Celeste, Helgadottir, Hildur, Queirolo, PaolaAff19, Aff20, Spagnolo, Francesco, Tucci, Marco, Del Vecchio, Michele, Cao, Maria Gonzales, Minisini, Alessandro Marco, De Placido, Sabino, Sanmamed, Miguel F., Mallardo, Domenico, Paone, Miriam, Vitale, Maria Grazia, Melero, Ignacio, Grimaldi, Antonio M.Aff1, Aff27, Giannarelli, Diana, Dummer, Reinhard, Sileni, Vanna Chiarion, Palmieri, Giuseppe
المصدر: Nature Communications. 15(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:20411723
DOI:10.1038/s41467-023-44475-6